A Prospective Phase II Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients Aged 61 Years And Older, With Classical Hodgkin Lymphoma And Coexisting Medical Conditions.
Phase of Trial: Phase II
Latest Information Update: 23 Mar 2019
Price : $35 *
At a glance
- Drugs Nivolumab (Primary) ; Vinblastine (Primary)
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 21 Aug 2018 Status changed from not yet recruiting to recruiting.
- 30 Apr 2018 New trial record